Latest Articles

Publication Date
All News Scientific
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer - OncLive

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer OncLive

Published: July 15, 2026, 3:58 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace

Published: July 15, 2026, 3:11 p.m.
Read Full Article
Simple Androgen Blood Test Could Identify Endometriosis With 95% Accuracy - Health and Me

Simple Androgen Blood Test Could Identify Endometriosis With 95% Accuracy Health and Me

Published: July 15, 2026, 12:30 p.m.
Read Full Article
‘If something doesn’t feel right, keep pushing until you are heard’ - echo live

‘If something doesn’t feel right, keep pushing until you are heard’ echo live

Published: July 15, 2026, noon
Read Full Article
‘Breakthrough’ finding could transform endometriosis diagnosis, scientists say - AOL.com

‘Breakthrough’ finding could transform endometriosis diagnosis, scientists say AOL.com

Published: July 15, 2026, 11:51 a.m.
Read Full Article
Merck's KEYTRUDA trial may offer a chemo-free option in endometrial cancer - Stock Titan

Merck's KEYTRUDA trial may offer a chemo-free option in endometrial cancer Stock Titan

Published: July 15, 2026, 10:48 a.m.
Read Full Article
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - Business Wire

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy Business Wire

Published: July 15, 2026, 10:45 a.m.
Read Full Article
A Blood Test For Endometriosis? Study Shows This One Is 95% Accurate - MindBodyGreen

A Blood Test For Endometriosis? Study Shows This One Is 95% Accurate MindBodyGreen

Published: July 15, 2026, 9:19 a.m.
Read Full Article
Meta’s $200 Billion Bet On A Remote Data Center Endometriosis (yYBZ7ujXvJ) - Mshale

Meta’s $200 Billion Bet On A Remote Data Center Endometriosis (yYBZ7ujXvJ) Mshale

Published: July 15, 2026, 5:53 a.m.
Read Full Article
Endometriosis Unveiled: Innovations in Diagnosis and Management of Endometriosis.

Endometriosis is a chronic inflammatory condition that can result in chronic pain through complex nociceptive, neuropathic, and nociplastic pathways. This article provides a comprehensive background on endometriosis as well as …

Published: July 15, 2026, midnight
Read Full Article
artificial intelligence chronic pelvic pain diagnostics endometriosis minimally invasive gynecologic surgery
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!